BIT Capital’s Cabaletta Bio CABA Stock Holding History

BIT Capital’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-190,000	Closed	-$431K	–	118
2024 Q4	$431K	Buy	+190,000	New	+$667K	0.03%	86
2022 Q4	–	Sell	-10,000	Closed	-$6.5K	–	139
2022 Q3	$6.5K	Hold	10,000	–	–	﹤0.01%	142
2022 Q2	$10.6K	Hold	10,000	–	–	﹤0.01%	112
2022 Q1	$20.3K	Hold	10,000	–	–	﹤0.01%	140
2021 Q4	$37.9K	Buy	+10,000	New	+$107K	﹤0.01%	115

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT Capital's CABA Position: Q1 2025 in Review

BIT Capital sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 190,000 shares — an estimated $431K sold.

BIT Capital first reported a position in CABA in Q4 2021 and held it in 5 quarters. The position peaked at $431K in Q4 2024. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

BIT Capital reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
BIT Capital sold 190,000 Cabaletta Bio shares in Q1 2025, an estimated $431K.
BIT Capital first reported a position in Cabaletta Bio in Q4 2021 and held it in 5 quarters.
BIT Capital's Cabaletta Bio position peaked at $431K in Q4 2024.
92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on BIT Capital's 13F filing for Q1 2025, filed 9 May 2025.